Abstract: Example implementations relate to creating a simulation environment. For example, a system for simulation environment creation may include a system controller. The system may also include a functional agent coupled to and executed by the system controller to create a simulation environment based on input comprising real user data and sensor data continuously received from a plurality of sources, perform tests within the simulation environment, continuously react to events occurring during the tests within the simulation environment, and continuously verify results of the tests.

Abstract: The present invention is based on the discovery of polymorphisms (SNPs) in the penicillin binding protein (pbp3) gene in Staphylococcus aureus. The presence of G88A and/or G2047A SNPs provides an accurate, reliable biomarker for the presence of Methicillin Resistant Staphylococcus aureus (MRSA), specifically the community-associated MRSA (CA-MRSA). The present invention provides reagents used for detecting the SNPs as well as methods of identifying and using these variants to screen subjects for presence of CA-MRSA. The methods involve isolating a biological sample from a mammal (preferably a human) and testing for the presence of a SNP in the pbp3 gene which is associated with CA-MRSA.

Abstract: Example implementations relate to determining a functional state of a system under test. For example, a system to determine a functional state of a system under test may include a system controller to execute a functional test of the system under test by invoking a subset of a plurality of functional agents to interact with the system under test. Further, the system may include an agent repository to interact with the system controller and store the plurality of functional agents. Also, the system may include a state module to determine a functional state for the system under test by querying each of the subset of functional agents and comparing aggregated results from the subset of functional agents against defined for the system under test.

Abstract: Disclosed are diagnostic methods for determining a subtype of methicillin-resistant Staphylococcus aureus (MRSA) in a biological sample of a mammal. Methods include providing a biological sample of the mammal, performing a PCR analysis of the biological sample, and analyzing the PCR amplicons with respect to their sizes so as to determine for type I, type II, type III, type IV or type V MRSA that may be present in the biological sample. Further example embodiments include using at least one mecA primer pair and/or using at least one Staphylococcus aureus nuc primer pair in the PCR analysis. Further disclosed are methods for screening populations for MRSA, and methods of treating a mammal testing positive for Type IV MRSA. Also disclosed are kits for determining a MRSA subtype in a mammal and isolated primers that may be used in the present methods and kits.

Abstract: In one implementation, a method for providing end-to-end communication security for a controller area network (CANbus) in an automotive vehicle across which a plurality of electronic control units (ECU) communicate is described. Such an automotive vehicle can include, for example, a car or truck with multiple different ECUs that are each configured to control various aspects of the vehicle's operation, such as an infotainment system, a navigation system, various engine control systems, and/or others.

Abstract: A method includes receiving, by a computer, input from a client device. The input is indicative of a software environment for software to be developed by a user. The method further includes analyzing, by the computer, the received input against a knowledge base to generate a technology recommendation for the user to use to develop the software. The method also includes providing, by the computer, the technology recommendation to the client device.

Abstract: A method for cycling GPS computations is described in which, at a beginning of a cycle, N computing devices are determined to be members of a device group. At each of N points within the cycle: a target device of the N computing devices is instructed to compute its target location data; another member of the device group is instructed to refrain from computing its other location data; target location data is received from the target device; and the target location data is transmitted to each other member of the device group.

Abstract: A method and kit related thereto are described for the collection and maintenance of detectability of a plurality of species of microbiological agents in a single clinical sample as well as an integral method for handling a plurality of the samples and managing information associated therewith for reporting a sum of diagnostic results for each sample.

Abstract: In one example of the disclosure, data indicative of a word or phrase communicated during a meeting including a plurality of participants is obtained. For each participant, records electronically accessible to the participant are identified, and each record is associated with a tier from a hierarchy of record-relevancy tiers. A set of explanations for the communication and associated scores is identified, including for each participant, beginning with a most relevant tier, searching the records accessible to the participant tier by tier until an explanation is identified, and assigning a score to the explanation according to the tier associated with the record in which the explanation is found. A preferred explanation for the communication is determined based upon the scores, and a display of the preferred explanation is caused.

Abstract: Examples disclosed herein relate to generating a fingerprint representing a response of an application to a simulation of a fault of an external service. Examples include causing simulation of a fault of an external service in a simulation of the external service, and generating a testing application fingerprint representing a response of an application to the simulation of the fault of the external service during the testing of the application.

Abstract: The present invention is based on the discovery of novel polymorphisms (SNPs) in the penicillin binding protein (pbp3) gene in Staphylococcus aureus. The presence of G88A and/or G2047A SNPs provides an accurate, reliable biomarker for the presence of Methicillin Resistant Staphylococcus aureus (MRSA), specifically the community-associated MRSA (CA-MRSA). The present invention provides reagents used for detecting the SNPs as well as methods of identifying and using these variants to screen subjects for presence of CA-MRSA. The methods involve isolating a biological sample from a mammal (preferably a human) and testing for the presence of a SNP in the pbp3 gene which is associated with CA-MRSA.

Abstract: The present invention relates to an antibiotic resistance profile for Neisseria gonorrhoeae by assessing the presence of mutations (e.g., SNP) in antibiotic resistant genes that confer bacterial resistance against antibiotics such as penicillin, tetracycline, fluoroquinolones, cephalosporin, macrolides and spectinomycin. There is provided a method and a kit for generating an antibiotic resistance profile for Neisseria gonorrhoeae by utilizing a multiplex PCR to amplify segments of antibiotic-resistant genes, allele-specific primer extension to detect gene mutation, and detection of such gene mutations with gel electrophoresis, capillary electrophoresis, or DNA microarray. The present method provides useful information to physicians relating the antibiotic susceptibility of Neisseria gonorrhoeae against different classes of antibiotics.

Abstract: The present invention is based on the discovery of polymorphisms (SNPs) in the penicillin binding protein (pbp3) gene in Staphylococcus aureus. The presence of G88A and/or G2047A SNPs provides an accurate, reliable biomarker for the presence of Methicillin Resistant Staphylococcus aureus (MRSA), specifically the community-associated MRSA (CA-MRSA). The present invention provides reagents used for detecting the SNPs as well as methods of identifying and using these variants to screen subjects for presence of CA-MRSA. The methods involve isolating a biological sample from a mammal (preferably a human) and testing for the presence of a SNP in the pbp3 gene which is associated with CA-MRSA.

Abstract: A monitor that monitors an application is provided herein. The monitor provides a monitor function that monitors an application. The monitor embeds the monitor function in meta data of a code base of the application. The monitor function embedded in the code base is activated. The monitor function is used to monitor data associated therewith during deployment of the application.

Abstract: A method is provided for receiving and handling a plurality of clinical samples and managing information associated therewith for generating and reporting any of a plurality of different diagnostic results from each sample in a timely manner, particularly within about thirty (30) hours. Methods described comprise, for example, receiving a plurality of single gynecological swab samples, each having identity and test requisition information associated therewith, wherein the test requisition information indicates a test for at least one causative agent, from a choice of a plurality of agents (for example, between about 5 and about 25 different microbiological agents) and managing information associated therewith for generating and reporting any of a plurality of different diagnostic results for each sample.

Abstract: The present invention is directed to the discovery of single nucleotide polymorphisms (SNPs) in the presence of metronidazole-resistant Trichomonas vaginalis. The presence of G76C, C213G, or C318A (SNP) in tvntr 4 or the presence of A238T, G427C, or T476C (SNP) in tvntr6 provides a reliable biomarker for the presence of metronidazole-resistant Trichomonas vaginalis. The present invention further provides reagents used for detecting the SNPs to screen subjects for metronidazole resistance in Trichomonas vaginalis.

Abstract: Recording an unstructured event in context can include detecting a first occurrence indicative of a start to the unstructured event utilizing a sensing feature of a client device. Upon detection of the first occurrence, device activity data associated with the client device is tracked. A second occurrence indicative an end to the unstructured event is detected utilizing the sensing feature. Following detection of the second occurrence, an event object for the unstructured event spanning between the first and second events is presented. The event object includes or is otherwise associated with the device activity data tracked during the timespan.

Abstract: In one example of the disclosure, data indicative of a word or phrase communicated during a meeting including a plurality of participants is obtained. For each participant, records electronically accessible to the participant are identified, and each record is associated with a tier from a hierarchy of record-relevancy tiers. A set of explanations for the communication and associated scores is identified, including for each participant, beginning with a most relevant tier, searching the records accessible to the participant tier by tier until an explanation is identified, and assigning a score to the explanation according to the tier associated with the record in which the explanation is found. A preferred explanation for the communication is determined based upon the scores, and a display of the preferred explanation is caused.

Abstract: A method and kit related thereto are described for the collection and maintenance of detectability of a plurality of species of microbiological agents in a single clinical sample as well as an integral method for handling a plurality of the samples and managing information associated therewith for reporting a sum of diagnostic results for each sample.

Abstract: A method and kit related thereto are described for the collection and maintenance of detectability of a plurality of species of microbiological agents in a single clinical sample as well as an integral method for handling a plurality of the samples and managing information associated therewith for reporting a sum of diagnostic results for each sample.